Methoxycarbonyl-L-tert-leucine CAS 162537-11-3 - Manufacturers, Factory, Suppliers from China

Methoxycarbonyl-L-tert-leucine CAS 162537-11-3, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

Moc-L-Tert-Leucine CAS 162537-11-3 Purity ≥99.0% (HPLC) Atazanavir Intermediate Factory
Read More

Z-HomoPhe-OH CAS 127862-89-9 Assay ≥98.0% (HPLC)

Z-Ser-OH CAS 1145-80-8 N-Cbz-L-Serine Assay ≥99.0% (HPLC)

Z-Hyp-OH CAS 13504-85-3 Purity ≥99.0% (HPLC)

N-Cbz-N-Methyl-L-Isoleucine CAS 42417-66-3 Purity ≥98.0% (HPLC)

D-2-Cyanophenylalanine CAS 263396-41-4 Assay ≥98.0% (HPLC)

D-3-Cyanophenylalanine CAS 263396-43-6 Assay ≥98.0% (HPLC)

Top Selling Products

Related Blog
Reviews

The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

6 October 2021 The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2021 to Benjamin List Max-Planck-Institut für Kohlenforschung, Mülheim an der Ruhr, Germany Da...
Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Focus on Cross Border Integration of Biomedicine and Chemical Materials: New Opportunities, New Technologies and New Models This forum focuses on the interdisciplinary and cutting-edge technologies...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

The Third Conference on Boron Chemistry of Chinese Chemical Society (CCS-CBS) will be held in Suzhou, Jiangsu Province from October 15 to 18, 2021. This conference will be hosted by Inorganic Chemi...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...

2022.10.23 05:21:24
2022.07.20 02:28:20
2022.04.13 11:11:13
2022.03.07 13:07:01
2021.11.06 21:08:02
2021.11.02 22:04:21

Methoxycarbonyl-L-tert-leucine CAS 162537-11-3 - Manufacturers, Factory, Suppliers from China

Related Products

Moc-L-Tert-Leucine CAS 162537-11-3 Purity ≥99.0% (HPLC) Atazanavir Intermediate Factory

Z-HomoPhe-OH CAS 127862-89-9 Assay ≥98.0% (HPLC)

Z-Ser-OH CAS 1145-80-8 N-Cbz-L-Serine Assay ≥99.0% (HPLC)

Z-Hyp-OH CAS 13504-85-3 Purity ≥99.0% (HPLC)

N-Cbz-N-Methyl-L-Isoleucine CAS 42417-66-3 Purity ≥98.0% (HPLC)

D-2-Cyanophenylalanine CAS 263396-41-4 Assay ≥98.0% (HPLC)

D-3-Cyanophenylalanine CAS 263396-43-6 Assay ≥98.0% (HPLC)

Top Selling Products

3-Methylsalicylic Acid CAS 83-40-9 Purity >98.0% (HPLC) Factory

H-D-Glu(OBzl)-OH CAS 2578-33-8 D-Glutamic Acid γ-Benzyl Ester Purity >99.0% (HPLC)

Dimethyl 5-Nitroisophthalate CAS 13290-96-5 Purity >99.0% (HPLC)

H-D-Phg-OEt·HCl CAS 17609-48-2 Assay ≥98.0% (HPLC)

1-Methylhomopiperazine CAS 4318-37-0 Purity >98.0% (GC)

D-(+)-Galactosamine Hydrochloride CAS 1772-03-8 Purity >99.0% (HPLC)

Carvedilol CAS 72956-09-3 Purity >99.0% (HPLC)

Ethyl 2-Methylacetoacetate CAS 609-14-3 Purity >99.0% (GC) Factory High Quality

(R)-(+)-3-Hydroxypiperidine Hydrochloride CAS 198976-43-1 Assay 98.0~101.0% (Titration)

Z-Asn-OH CAS 2304-96-3 Nα-Cbz-L-Asparagine Purity >99.0% (HPLC) Factory

Z-D-Gln-OH CAS 13139-52-1 Purity >98.0% (HPLC)

1,1,4,4,5,5,8,8-Octamethyl-1,2,3,4,5,6,7,8-Octahydroanthracene CAS 22306-30-5 Purity ≥98.0% (HPLC)

The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

Paxlovid: what we know about Pfizer's Covid-19 pill

New COVID treatments offer hope

2022.10.23 05:21:24

2022.07.20 02:28:20

2022.04.13 11:11:13

2022.03.07 13:07:01

2021.11.06 21:08:02

2021.11.02 22:04:21

related search